The Growing Menace of Community-Acquired Methicillin-Resistant Staphylococcus aureus

Editorials7 March 2006The Growing Menace of Community-Acquired Methicillin-Resistant Staphylococcus aureusRobert C. Moellering Jr., MDRobert C. Moellering Jr., MDFrom Beth Israel Deaconess Medical Center, Boston, MA 02215.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-144-5-200603070-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail As we read anxiously about the possibility of a worldwide pandemic of avian influenza, another epidemic is actually happening in the United States and elsewhere. Methicillin-resistant strains of Staphylococcus aureus (MRSA) have now emerged as community-acquired pathogens capable of causing serious disease. We have known about MRSA since the early 1960s (1). Until recently, however, infection with these strains was primarily limited to hospitals and other institutional settings. Sporadic reports of community-acquired (or community-associated) MRSA infections have appeared since 1980, but 1999 marked the beginning of the current epidemic in the United States. The sentinel event was a series of ...References1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-32. [PMID: 9709046] CrossrefMedlineGoogle Scholar2. Rybak MJ, LaPlante KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy. 2005;25:74-85. [PMID: 15767223] CrossrefMedlineGoogle Scholar3. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006;144:309-17. LinkGoogle Scholar4. Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40:1785-91. [PMID: 15909267] CrossrefMedlineGoogle Scholar5. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-84. [PMID: 14665659] CrossrefMedlineGoogle Scholar6. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-27. [PMID: 12044378] CrossrefMedlineGoogle Scholar7. Chambers HF. Community-associated MRSA—resistance and virulence converge [Editorial]. N Engl J Med. 2005;352:1485-7. [PMID: 15814886] CrossrefMedlineGoogle Scholar8. Banthia S, Meka VG, Pillai S, Wener K, Freedman R, Pandya S, et al. A fatal case of necrotizing pneumonia caused by community-associated methicillin-resistant Staphylococcus aureus. Infectious Diseases in Clinical Practice. 2005;13:132-8. CrossrefGoogle Scholar9. Gonzalez BE, Hulten KG, Dishop MK, Lamberth LB, Hammerman WA, Mason EO, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005;41:583-90. [PMID: 16080077] CrossrefMedlineGoogle Scholar10. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445-53. [PMID: 15814880] CrossrefMedlineGoogle Scholar11. Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, Humilier M, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. 2005;353:1245-51. [PMID: 16177250] CrossrefMedlineGoogle Scholar12. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40:100-7. [PMID: 15614698] CrossrefMedlineGoogle Scholar13. Graham PL, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med. 2006;144:318-25. LinkGoogle Scholar14. Boyce JM, Havill NL, Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005;43:5992-5. [PMID: 16333087] CrossrefMedlineGoogle Scholar15. van Duijkeren E, Wolfhagen MJ, Heck ME, Wannet WJ. Transmission of a Panton-Valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J Clin Microbiol. 2005;43:6209-11. [PMID: 16333133] CrossrefMedlineGoogle Scholar16. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004;39:1460-6. [PMID: 15546082] CrossrefMedlineGoogle Scholar17. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003;37:1257-60. [PMID: 14557972] CrossrefMedlineGoogle Scholar18. Gauduchon V, Cozon G, Vandenesch F, Genestier AL, Eyssade N, Peyrol S, et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis. 2004;189:346-53. [PMID: 14722901] CrossrefMedlineGoogle Scholar19. Highlander S, Hulten K, Yerrapragada S, Quin X, Jiang H, Mason E, et al. Genome sequence of Staphylococcus aureus USA300, a dominant community-acquired MRSA [Abstract]. In: Abstracts of 45th Interscience Conference of Antimicrobial Agents and Chemotherapy, Washington, DC, 16–19 December 2005. Abstract no. LB2-17. Google Scholar Author, Article, and Disclosure InformationAuthors: Robert C. MoelleringJr., MDAffiliations: From Beth Israel Deaconess Medical Center, Boston, MA 02215.Disclosures: Consultancies: R.C. Moellering (Pfizer Inc., Cubist Pharmaceuticals); Honoraria: R.C. Moellering (Pfizer Inc., Cubist Pharmaceuticals); Grants received: R.C. Moellering (Pfizer Inc., Cubist Pharmaceuticals).Corresponding Author: Robert C. Moellering Jr., MD, Department of Medicine, Beth Israel Deaconess Medical Center, 110 Francis Street, Suite 6A, Boston, MA 02215. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoEmergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections Mark D. King , Bianca J. Humphrey , Yun F. Wang , Ekaterina V. Kourbatova , Susan M. Ray , and Henry M. Blumberg A U.S. Population-Based Survey of Staphylococcus aureus Colonization Philip L. Graham III , Susan X. Lin , and Elaine L. Larson Treatment of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection Henry M. Blumberg , Susan M. Ray , and Mark D. King Metrics Cited byMethicillin resistant Staphylococcus aureus (MRSA) from community associated settingsIntestinal Flora: A Potential Mechanism by Which Yinlai Decoction Treats Lipopolysaccharide-Induced PneumoniaMRSA-induced endothelial permeability and acute lung injury are attenuated by FTY720 S-phosphonateRecent Developments in Phenotypic and Molecular Diagnostic Methods for Antimicrobial Resistance Detection in Staphylococcus aureus: A Narrative ReviewEffect of naturally isolated hydroquinone in disturbing the cell membrane integrity of Pseudomonas aeruginosa MTCC 741 and Staphylococcus aureus MTCC 740Comparative analysis of Methicillin-Resistant Staphylococcus aureus (MRSA) and Borderline Oxacillin Resistant Staphylococcus aureus (BORSA) in community and food of animal originAnalysis of phenotypic antibiotic resistance profile of Staphylococcus aureus from community settings of a university campusDecoding inflammation, its causes, genomic responses, and emerging countermeasuresA human monoclonal antibody that specifically binds and inhibits the staphylococcal complement inhibitor protein SCINNovel potential synthetic compounds from thiazolidin-4-one for infectious diseasesPhenotypic and genetic characteristics of fluoroquinolone- and methicillin-resistant Staphylococcus aureusPhenotypic and genetic characteristics of fluoroquinolone- and methicillin-resistant Staphylococcus aureusAn Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureusElucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosaImpact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic TargetThe bactericidal effect of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus (MRSA)Optimization of the antimicrobial effect of blue light on methicillin-resistant Staphylococcus aureus (MRSA) in vitroA randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infectionsAntibacterial Activity of Some Compounds Isolated from Aristolochia brevipes and One Derivative of 9-methoxytariacuripyrone, Against Multiresistant Methicillin-Susceptible Staphylococcus aureus (MR-MSSA)High Nasal Carriage of Methicillin-Resistant Staphylococcus aureus Among Healthy Tanzanian Under-5 ChildrenIs Community-Acquired Methicillin-Resistant Staphylococcus aureus Coverage Needed for Cellulitis?Wavelength and Bacterial Density Influence the Bactericidal Effect of Blue Light on Methicillin-Resistant Staphylococcus aureus (MRSA)Antimicrobial Blue Light: An Emerging Alternative to AntibioticsInadequate Postgraduate Training of Skin and Soft Tissue Infections in an Era of Community-Associated Methicillin-Resistant Staphylococcus aureusDiversity of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Isolated from Inpatients of 30 Hospitals in Orange County, CaliforniaEditorial Commentary: Unraveling the Dynamics of Community-Associated Methicillin-Resistant Staphylococcus aureusIn vitro antimicrobial activity of pistachio ( Pistacia vera L.) polyphenolsSpinal Cord InfectionsCost–effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infectionsOvercoming the challenges to developing new antibioticsDifferences in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Pediatric and Adult Patients from Hospitals in a Large County in CaliforniaNeurologic Infectious Disease EmergenciesMRSA: the first half centuryTreatment of MRSA soft tissue infections: An overviewCellulitis: Definition, Etiology, and Clinical FeaturesAntimicrobial activity of Blumea balsamifera (Lin.) DC. extracts and essential oilRecent advances in understanding the antibacterial properties of flavonoidsCombating Antimicrobial Resistance: Policy Recommendations to Save LivesMethicillin-Resistant Staphylococcus aureus USA300 Clone as a Cause of Lemierre's SyndromeCase 2-2011Other Sexually Transmitted InfectionsResistencia a los antibióticos y unidad de cuidados críticosRelationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated PneumoniaClinical and economic outcomes in patients with community‐acquired Staphylococcus aureus pneumoniaSi+ ion implantation reduces the bacterial accumulation on the Ti6Al4V surfaceThe problem of complicated skin and skin structure infections: the need for new agentsMethicillin-resistant Staphylococcus aureus: related infections and antibiotic resistanceTracing the Source of an Outbreak of Methicillin-Resistant Staphylococcus aureus in a Tertiary-Care Oncology Hospital by Epidemiology and Molecular MethodsWhy Has Methicillin-Resistant Staphylococcus aureus Become Such a Successful Pathogen in Adults?An Overview of Livestock-Associated MRSA in AgricultureEfficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysisMethicillin-resistant Staphylococcus aureus : an update for the dermatologistPneumoniaNovel pharmaceutical molecules against emerging resistant gram-positive cocciNew treatments for methicillin-resistant Staphylococcus aureusUnmet Needs for the Treatment of Moderate-to-Severe or Hospitalized Community-Acquired PneumoniaStaphylococcus aureus Not Always Right Under Your NosePharmacodynamics of SMP-601 (PTZ601) against Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus in Neutropenic Murine Thigh Infection ModelsCeftobiprole: a new broad spectrum cephalosporinSuppression of Acute Lung Inflammation by Intracellular Peptide Delivery of a Nuclear Import InhibitorRevision of a Treatment Algorithm for Community-Associated Methicillin-Resistant Staphylococcus Aureus Skin InfectionsBlue 470-nm Light Kills Methicillin-Resistant Staphylococcus aureus (MRSA) in VitroPresence and Molecular Epidemiology of Virulence Factors in Methicillin-Resistant Staphylococcus aureus Strains Colonizing and Infecting SoldiersVariables to be considered when assessing the photocatalytic destruction of bacterial pathogensCost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic modelIncreased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activityNasal carriage of Staphylococcus aureus, including community-associated methicillin-resistant strains, in Queensland adultsThe Epidemiology of Bacterial Resistance to Antimicrobial AgentsSevere Staphylococcal Cutaneous Infections and Toxic Shock SyndromeShort-course therapy for bloodstream infections in immunocompetent adultsVisible 405 nm SLD light photo-destroys methicillin-resistant Staphylococcus aureus (MRSA) in vitroActivity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiaeStaphylococcus aureus resistente a la meticilina de origen comunitarioManagement of Skin and Soft-Tissue InfectionPrevention and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in adultsA new lipoglycopeptide: telavancinCommunity-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Colonization and Infection in Intravenous and Inhalational Opiate Drug AbusersGlobal Implications of the Emergence of Community‐Associated Methicillin‐Resistant Staphylococcus aureus in Indigenous PopulationsCommunity-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton–Valentine leukocidin-positive isolatesSkin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐Resistant Staphylococcus aureusVigilancia y control de Staphylococcus aureus resistente a meticilina en hospitales españoles. Documento de consenso GEIH-SEIMC y SEMPSPHUpdate on bacterial pathogens: virulence and resistanceLes souches de Staphylococcus aureus méticilline-résistant communautaires en consultation externe hospitalière de dermatologieCurrent Treatment Options for Community‐Acquired Methicillin‐Resistant Staphylococcus aureus InfectionThe evaluation and treatment of complicated skin and skin structure infectionsCellulitis and Skin Infections Associated with BitesCurrent Treatment Options for Community-Acquired Methicillin-Resistant Staphylococcus aureus InfectionCommunity-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Problem in the Athletic PopulationCommunity-Onset Methicillin-Resistant Staphylococcus aureus Skin and Soft-Tissue Infections: Impact of Antimicrobial Therapy on OutcomeNew antimicrobial agents as therapy for resistant gram-positive cocciCellulitis and the role of the Clinical Microbiology LaboratoryCommunity-associated methicillin-resistant Staphylococcus aureus prevalence: How common is it? A methodological comparison of prevalence ascertainmentBurden of Methicillin-Resistant Staphylococcus aureus : Focus on Clinical and Economic OutcomesEpidemiology and Outcomes of Community-Associated Methicillin-Resistant Staphylococcus aureus InfectionMechanisms of antibiotic resistance in Staphylococcus aureusIn Vivo Pharmacodynamic Activity of the Glycopeptide DalbavancinCommunity-Onset Methicillin-Resistant Staphylococcus aureus Skin and Soft-Tissue Infections: Impact of Antimicrobial Therapy on OutcomeCommunity Associated Methicillin Resistant Staphylococcus Aureus Causing Fournier's Gangrene and Genital InfectionsHeterosexual Transmission of Community-Associated Methicillin-Resistant Staphylococcus aureusTreatment and Outcomes of Infections by Methicillin-Resistant Staphylococcus aureus at an Ambulatory ClinicA U.S. Population-Based Survey of Staphylococcus aureus ColonizationEpidemiology and Economic Impact??of Meticillin-Resistant Staphylococcus aureusCosts of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its controlAntimicrobial Therapy of Multidrug-Resistant Streptococcus pneumoniae, Vancomycin-Resistant Enterococci, and Methicillin-Resistant Staphylococcus aureusUse of a Single-Nucleotide Polymorphism Genotyping System To Demonstrate the Unique Epidemiology of Methicillin-Resistant Staphylococcus aureus in Remote Aboriginal CommunitiesCommunity-acquired MRSA: can we control it?Treatment of Community-Acquired Methicillin-Resistant Staphylococcus aureus InfectionHenry M. Blumberg, MD, Susan M. Ray, MD, and Mark D. King, MD, MScPotential Consequences of the Pneumococcal Conjugate VaccineCarriage of methicillin‐resistant Staphylococcus aureus in a Queensland Indigenous community 7 March 2006Volume 144, Issue 5Page: 368-370KeywordsAbscessesAntimicrobialsChildrenClindamycinEpidemiologyMethicillin-resistant staphylococcus aureusPediatric infectionsPopulation statisticsSkin infectionsToxins ePublished: 7 March 2006 Issue Published: 7 March 2006 Copyright & PermissionsCopyright © 2006 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...